Homozygous R788W point mutation in the XPF gene of a patient with Xeroderma pigmentosum and late-onset neurologic disease

被引:56
|
作者
Sijbers, AM
Vader, PCV
Snoek, JW
Raams, A
Jaspers, NGJ
Kleijer, WJ
机构
[1] Erasmus Univ, Dept Genet & Cell Biol, NL-3000 DR Rotterdam, Netherlands
[2] Erasmus Univ, Dept Clin Genet, NL-3000 DR Rotterdam, Netherlands
[3] Univ Groningen Hosp, Dept Dermatol, Groningen, Netherlands
[4] Martini Hosp, Groningen, Netherlands
关键词
ERCC1; nucleotide excision repair; skin cancer;
D O I
10.1046/j.1523-1747.1998.00171.x
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
The second Caucasian xeroderma pigmentosum patient (XP42RO) belonging to complementation group F (XP-F) is described, Mild ocular photophobia was present from childhood, and acute skin reactions occurred upon exposure to sunlight. Basal and squamous cell carcinomas developed after his twenty-seventh year, In his late forties progressive neurologic symptoms emerged, which included intellectual decline, mild chorea and ataxia, and marked cerebral and cerebelar atrophy, Such neurologic abnormalities are very unusual in XP-F, Similar symptoms have been described in only one of 17 other XP-F individuals. His approximate to 5-fold reduced activity of nucleotide excision repair in cultured cells, combined with moderately affected cell survival and DNA replication after UV exposure, are typical of XP-F., The recent cloning of the XPF gene allowed a molecular genetic analysis of this unusual patient, XP42RO, representing the second case studied in this respect, turned out to be homozygous for a point mutation in the XPF gene, causing an R788-->W substitution in the encoded protein, Surprisingly, this mutation had also been found in one allele of the other unrelated Caucasian XP-F case. The amount of mutated XPF protein is strongly reduced in cells from XP42RO, presumably due to a conformational change. Biochemical, genetic, and clinical data all indicate the presence of considerable residual repair activity, strongly suggesting that the R788W mutation is leaky.
引用
收藏
页码:832 / 836
页数:5
相关论文
共 50 条
  • [1] Cobalamin C defect: a patient of late-onset type with homozygous p. R132*mutation
    Kilic, Mustafa
    Ozgul, Riza Koksal
    Dursun, Ali
    Tokatli, Aysegul
    Kalkanoglu-Sivri, Hatice Serap
    Anlar, Banu
    Fowler, Brian
    Coskun, Turgay
    TURKISH JOURNAL OF PEDIATRICS, 2013, 55 (06) : 633 - 636
  • [2] Late-onset spastic ataxia phenotype in a patient with a homozygous DDHD2 mutation
    Hiroshi Doi
    Masao Ushiyama
    Takashi Baba
    Katsuko Tani
    Masaaki Shiina
    Kazuhiro Ogata
    Satoko Miyatake
    Yoko Fukuda-Yuzawa
    Shoji Tsuji
    Mitsuko Nakashima
    Yoshinori Tsurusaki
    Noriko Miyake
    Hirotomo Saitsu
    Shu-ichi Ikeda
    Fumiaki Tanaka
    Naomichi Matsumoto
    Kunihiro Yoshida
    Scientific Reports, 4
  • [3] Late-onset spastic ataxia phenotype in a patient with a homozygous DDHD2 mutation
    Doi, Hiroshi
    Ushiyama, Masao
    Baba, Takashi
    Tani, Katsuko
    Shiina, Masaaki
    Ogata, Kazuhiro
    Miyatake, Satoko
    Fukuda-Yuzawa, Yoko
    Tsuji, Shoji
    Nakashima, Mitsuko
    Tsurusaki, Yoshinori
    Miyake, Noriko
    Saitsu, Hirotomo
    Ikeda, Shu-ichi
    Tanaka, Fumiaki
    Matsumoto, Naomichi
    Yoshida, Kunihiro
    SCIENTIFIC REPORTS, 2014, 4
  • [4] Late-onset nonketotic hyperglycinemia caused by a novel homozygous missense mutation in the GLDC gene
    Brunel-Guitton, Catherine
    Casey, Brett
    Coulter-Mackie, Marion
    Vallance, Hilary
    Hewes, Deborah
    Stockler-Ipsiroglu, Sylvia
    Mercimek-Mahmutoglu, Saadet
    MOLECULAR GENETICS AND METABOLISM, 2011, 103 (02) : 193 - 196
  • [5] A novel GFAP mutation in a very late-onset Alexander disease patient
    Rastgardani, T.
    Lang, A.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2017, 381 : 892 - 892
  • [6] Late-Onset Nonketotic Hyperglycinemia With a Heterozygous Novel Point Mutation of the GLDC Gene
    Brenton, J. Nicholas
    Rust, Robert S.
    PEDIATRIC NEUROLOGY, 2014, 50 (05) : 536 - 538
  • [8] Living with late-onset Pompe disease: the patient and clinician point of view
    Patel, N.
    Sathe, S.
    Dietze, D.
    Viereck, C.
    Barth, J.
    Sitaraman, S.
    NEUROMUSCULAR DISORDERS, 2017, 27 : S163 - S163
  • [9] The patient and clinician point of view: living with late-onset Pompe disease
    Patel, Nita
    Kishnani, Priya
    Sathe, Swati
    Dietze, Derek
    Viereck, Christopher
    Barth, Jay A.
    Sitaraman, Sheela
    MOLECULAR GENETICS AND METABOLISM, 2018, 123 (02) : S114 - S115
  • [10] Late-onset holocarboxylase synthetase deficiency with homologous R508W mutation
    Hwu, WL
    Suzuki, Y
    Yang, X
    Li, X
    Chou, SP
    Narisawa, K
    Tsai, WY
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2000, 99 (02) : 174 - 177